Josh Mandel-Brehm - 2022 World Medical Innovation Forum
Josh Mandel-Brehm
This speaker appears at this event:

Josh Mandel-Brehm

President & CEO, CAMP4 Therapeutics

Josh Mandel-Brehm is President & Chief Executive Officer of CAMP4 Therapeutics. He is also a co-founder and board director for Vico Therapeutics, and independent director for ProMIS neurosciences.

Mr. Mandel-Brehm previously held key business development and operations leadership roles at leading biotech companies. Most recently he served as part of the Business Development group at Biogen, where he led multiple strategic activities and corresponding transactions. Prior to Biogen, Mr. Mandel-Brehm held several roles of increasing responsibility at Genzyme as part of the business development group for the company’s rare disease business unit.

Mr. Mandel-Brehm earned a BA in Biology from Washington University in St. Louis and holds an MBA from the University of Michigan.